DNAJC5 and malaria: Interestingly, in the Phase III trial, we detected TH1 responses in supernatants of CSP-stimulated cells associated with protection in RTS,S/AS01E vaccinees, whereas a TH2 cytokine, IL-5, was associated with increased risk for malaria (16).